Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 2, 2008, Pages 410-415

  Dong, Lifang ^a   Yan, Hong ^a   Wang, Duolao ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antibiotic prescriptions; Pharmacoepidemiology; Rural population

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMPICILLIN; CEFALEXIN; CEFAZOLIN; CEFRADINE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LINCOMYCIN; MACROLIDE; METRONIDAZOLE; MICRONOMICIN; NORFLOXACIN; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPIRAMYCIN; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHINA; DEVELOPED COUNTRY; DRUG UTILIZATION; FEMALE; HEALTH CENTER; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIMARY HEALTH CARE; QUANTITATIVE ANALYSIS; RURAL AREA; RURAL POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; RURAL POPULATION;

EID: 47249110951     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn153     Document Type: Article

References (24)

1. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006; 119: S3-10; discussion S62-70.
2. Russell AD, Tattawasart U, Maillard JY et al. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother 1998; 42: 2151.
3. Arason VA, Sigurdsson JA, Erlendsdottir H et al. The role of antimicrobial use in the epidemiology of resistant pneumococci: A 10-year follow up. Microb Drug Resist 2006; 12: 169-76.
4. Paulsen IT, Banerjei L, Myers GS et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 2003; 299: 2071-4.
5. Neu HC. The crisis in antibiotic resistance. Science 1992; 257 1064-73.
6. Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ 1999; 319: 1239-40.
7. Zhang R, Eggleston K, Rotimi V et al. Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States. Global Health 2006; 2: 6.
8. Odusanya OO. Drug use indicators at a secondary health care facility in Lagos, Nigeria. J Community Med Prim Health Care 2004; 16: 21-4.
9. Chalker J. Improving antibiotic prescribing in Hai Phong Province, Viet Nam: The 'antibiotic-dose' indicator. Bull World Health Organ 2001; 79: 313-20.
10. Hamadeh GN, Dickerson LM, Saab BR et al. Common prescriptions in ambulatory care in Lebanon. Ann Pharmacother 2001; 35: 636-40.
11. Roumie CL, Halasa NB, Grijalva CG et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005; 20: 697-702.
12. Bjerrum L, Cots JM, Llor C et al. Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: A prospective, before and after study in general practice. J Gen Intern Med 2006; 62: 913-8.
13. Glowacki RC, Schwartz DN, Itokazu GS et al. Antibiotic combinations with redundant antimicrobial spectra: Clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003; 37: 59-64.
14. Vaccheri A, Bjerrum L, Resi D et al. Antibiotic prescribing in general practice: Striking differences between Italy (Ravenna) and Denmark (Funen). J Antimicrob Chemother 2002; 50: 989-97.
15. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe. J Antimicrob Chemother 2006; 58: 401-7.
16. Ferech M, Coenen S, Dvorakova K et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient penicillin use in Europe. J Antimicrob Chemother 2006; 58: 408-12.
17. Coenen S, Ferech M, Dvorakova K et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient cephalosporin use in Europe. J Antimicrob Chemother 2006; 58: 413-7.
18. Coenen S, Ferech M, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006; 58: 418-22.
19. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient quinolone use in Europe. J Antimicrob Chemother 2006; 58: 423-7.
20. Kaye KS, Cosgrove S, Harris A et al. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 2001; 45: 2628-30.
21. Fridkin SK, Edwards JR, Courval JM et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001; 135: 175-83.
22. Muller A, Lopez-Lozano JM, Bertrand X et al. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J Antimicrob Chemother 2004; 54: 173-7.
23. Lee SO, Lee ES, Park SY et al. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25: 832-7.
24. Lan CK, Hsueh PR, Wong WW et al. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum β-lactamase-producing organisms. J Microbiol Immunol Infect 2003; 36: 182-6.